Literature DB >> 15459153

Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis.

E Bargagli, M Galeazzi, P Rottoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15459153     DOI： 10.1183/09031936.04.00076904

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  16 in total

Review 1.  Lung disease in rheumatoid arthritis.

Authors:  Zulma X Yunt; Joshua J Solomon
Journal:  Rheum Dis Clin North Am       Date:  2015-02-03       Impact factor: 2.670

2.  SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

Authors:  Sabina Sangaletti; Claudio Tripodo; Barbara Cappetti; Patrizia Casalini; Claudia Chiodoni; Silvia Piconese; Alessandra Santangelo; Mariella Parenza; Ivano Arioli; Silvia Miotti; Mario P Colombo
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

3.  Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.

Authors:  Md Yuzaiful Md Yusof; Angela Kabia; Michael Darby; Giovanni Lettieri; Paul Beirne; Edward M Vital; Shouvik Dass; Paul Emery
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

Review 4.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

5.  Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.

Authors:  Nejat Altintas; Mustafa Erboga; Cevat Aktas; Bulent Bilir; Murat Aydin; Aysun Sengul; Zehra Ates; Birol Topcu; Ahmet Gurel
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

6.  Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment.

Authors:  Hirofumi Taki; Yukio Kawagishi; Koichiro Shinoda; Hiroyuki Hounoki; Reina Ogawa; Eiji Sugiyama; Kazuyuki Tobe
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

7.  Prevalence and characteristics of lung involvement on high resolution computed tomography in patients with ankylosing spondylitis: a systematic review.

Authors:  Abdellah El Maghraoui; Mohamed Dehhaoui
Journal:  Pulm Med       Date:  2012-02-22

8.  Treatment with etanercept in a patient with rheumatoid arthritis-associated interstitial lung disease.

Authors:  Yu Wang; Sheng-Qian Xu; Jian-Hua Xu; Changhai Ding
Journal:  Clin Med Insights Case Rep       Date:  2011-10-06

9.  Interstitial lung disease in rheumatoid arthritis in the era of biologics.

Authors:  A Picchianti Diamanti; V Germano; E Bizzi; B Laganà; A Migliore
Journal:  Pulm Med       Date:  2011-12-20

Review 10.  The safety of biologic therapies in RA-associated interstitial lung disease.

Authors:  Meghna Jani; Nik Hirani; Eric L Matteson; William G Dixon
Journal:  Nat Rev Rheumatol       Date:  2013-12-24       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.